tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CVKD Stock Latest News

Cadrenal Highlights Mixed Phase 2 Results for CAD-1005
Company AnnouncementsCadrenal Highlights Mixed Phase 2 Results for CAD-1005
18h ago
8K
CVKD
Cadrenal Therapeutics announces Phase 2 results for CAD-1005
PremiumThe Fly
Cadrenal Therapeutics announces Phase 2 results for CAD-1005
19h ago
CVKD
Cadrenal Therapeutics highlights VLX-1005 as potential therapeutic solution
PremiumThe Fly
Cadrenal Therapeutics highlights VLX-1005 as potential therapeutic solution
1M ago
CVKD
Cadrenal Therapeutics Expands At-The-Market Stock Offering Capacity
PremiumCompany Announcements
Cadrenal Therapeutics Expands At-The-Market Stock Offering Capacity
2M ago
8K
CVKD
Cadrenal Therapeutics Announces New Securities Purchase Agreement
PremiumCompany Announcements
Cadrenal Therapeutics Announces New Securities Purchase Agreement
2M ago
8K
CVKD
Cadrenal Therapeutics Acquires VLX-1005 from Veralox
PremiumCompany AnnouncementsCadrenal Therapeutics Acquires VLX-1005 from Veralox
3M ago
8K
CVKD
Cadrenal Therapeutics acquires VLX-1005 for heparin-induced thrombocytopenia
Premium
The Fly
Cadrenal Therapeutics acquires VLX-1005 for heparin-induced thrombocytopenia
3M ago
CVKD
Cadrenal Therapeutics Appoints Dr. Golden to Board
Premium
Company Announcements
Cadrenal Therapeutics Appoints Dr. Golden to Board
3M ago
8K
CVKD
Cadrenal Therapeutics appoints Lee Golden to board of directors
PremiumThe Fly
Cadrenal Therapeutics appoints Lee Golden to board of directors
3M ago
CVKD
PTCT
Cadrenal Therapeutics Announces New Stock Offering Program
PremiumCompany Announcements
Cadrenal Therapeutics Announces New Stock Offering Program
3M ago
8K
CVKD
Cadrenal Therapeutics Reports Increased Losses Amid Strategic Expansion
PremiumCompany Announcements
Cadrenal Therapeutics Reports Increased Losses Amid Strategic Expansion
4M ago
CVKD
Cadrenal Therapeutics reports Q3 EPS ($1.31) vs ($2.18) last year
PremiumThe Fly
Cadrenal Therapeutics reports Q3 EPS ($1.31) vs ($2.18) last year
4M ago
CVKD
Cadrenal Therapeutics Elects New Director at Meeting
PremiumCompany AnnouncementsCadrenal Therapeutics Elects New Director at Meeting
5M ago
8K
CVKD
Cadrenal Therapeutics Acquires eXIthera’s Assets for Growth
Premium
Company Announcements
Cadrenal Therapeutics Acquires eXIthera’s Assets for Growth
5M ago
8K
CVKD
Cadrenal announces acquisition of assets of eXIthera Pharmaceuticals
Premium
The Fly
Cadrenal announces acquisition of assets of eXIthera Pharmaceuticals
5M ago
CVKD
Cadrenal Therapeutics Advances Tecarfarin Development
PremiumCompany Announcements
Cadrenal Therapeutics Advances Tecarfarin Development
7M ago
CVKD
Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)
PremiumThe Fly
Cadrenal Therapeutics reports Q2 EPS ($1.87), consensus ($1.77)
7M ago
CVKD
Cadrenal Therapeutics to Initiate Tecarfarin Clinical Trial
PremiumCompany Announcements
Cadrenal Therapeutics to Initiate Tecarfarin Clinical Trial
7M ago
8K
CVKD
Cadrenal Therapeutics announces trial plans for tecarfarin
PremiumThe Fly
Cadrenal Therapeutics announces trial plans for tecarfarin
7M ago
CVKD
Cadrenal Therapeutics Director Resignation Announced
PremiumCompany AnnouncementsCadrenal Therapeutics Director Resignation Announced
7M ago
8K
CVKD
Positive Outlook for Cadrenal Therapeutics, Inc. Amid Strategic Developments and FDA Trial Milestone
Premium
Ratings
Positive Outlook for Cadrenal Therapeutics, Inc. Amid Strategic Developments and FDA Trial Milestone
9M ago
CVKD
Cadrenal Therapeutics Reports Increased Losses Amid R&D Expansion
Premium
Company Announcements
Cadrenal Therapeutics Reports Increased Losses Amid R&D Expansion
10M ago
CVKD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >